New Mexico Oncology & Hematology Consultants

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer	Carcinoma, Ductal, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Skin and Connective Tissue Diseases, adenocarcinoma, breast disorder, breast ductal adenocarcinoma, breast neoplasm, carcinoma, epithelial neoplasm, neoplasm, skin disorder	Recruiting	Not applicable	2026-09-23		NCT07214532

Clinical trials